Moore Kuehn Encourages BIOT, VGII, CPTK, and DSAC Investors to Contact Law Firm NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...

Moore Kuehn Encourages MNR, DSAC, BIOT, and ZIXI Investors to Contact Law Firm NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...

OnCore Biopharma Agrees to Acquire Enantigen Therapeutics DOYLESTOWN, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral...